A cross-sectional study assessing dietary intake and physical activity in canadian patients with nonalcoholic fatty liver disease vs healthy controls

Journal of the Academy of Nutrition and Dietetics

Volumn 114, Issue 8, 2014, Pages 1181-1194

  Da Silva, Hannah E ^a   Arendt, Bianca M ^b   Noureldin, Seham A ^b,c   Therapondos, George ^b,d   Guindi, Maha ^e,f   Allard, Johane P ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d OCHSNER CLINIC FOUNDATION   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Diet; Nonalcoholic fatty liver disease; Nutrient intake; Physical activity; Steatohepatitis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CALORIC INTAKE; CANADA; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DIET; FAT INTAKE; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; MEDICAL RECORD; MIDDLE AGED; MOTOR ACTIVITY; NONALCOHOLIC FATTY LIVER; NORMAL HUMAN; NUTRIENT INTAKE; NUTRITIONAL ASSESSMENT; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SODIUM INTAKE; STEATOHEPATITIS; YOUNG ADULT;

DIET; NONALCOHOLIC FATTY LIVER DISEASE; NUTRIENT INTAKE; PHYSICAL ACTIVITY; STEATOHEPATITIS;

ADULT; AGED; ASCORBIC ACID; BODY MASS INDEX; CANADA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIET RECORDS; DIETARY FATS; ENERGY INTAKE; FATTY LIVER; FEMALE; GUIDELINES AS TOPIC; HEALTHY VOLUNTEERS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MOTOR ACTIVITY; NUTRITION ASSESSMENT; PROSPECTIVE STUDIES; SODIUM, DIETARY; VITAMIN D; VITAMIN E; YOUNG ADULT;

EID: 84904760759     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2014.01.009     Document Type: Article

References (89)

1. Bellentani S., Scaglioni F., Marino M., Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010, 28(1):155-161.
2. Erickson S.K. Nonalcoholic fatty liver disease. JLipid Res 2009, 50(suppl):S412-S416.
3. Frith J., Day C.P., Robinson L., Elliott C., Jones D.E., Newton J.L. Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. JHepatol 2010, 52(1):112-116.
4. Scaglioni F., Ciccia S., Marino M., Bedogni G., Bellentani S. ASH and NASH. Dig Dis 2011, 29(2):202-210.
5. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006, 43(2 suppl 1):S99-S112.
6. Havenaar R. Intestinal health functions of colonic microbial metabolites: A review. Benef Microbes 2011, 2(2):103-114.
7. York L.W., Puthalapattu S., Wu G.Y. Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 2009, 29:365-379.
8. Musso G., Gambino R., Cassader M. Recent insights into hepatic lipidmetabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009, 48(1):1-26.
9. Lau D.C., Douketis J.D., Morrison K.M., Hramiak I.M., Sharma A.M., Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007, 176(8):S1-S13.
10. Capristo E., Miele L., Forgione A., et al. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). Eur Rev Med Pharmacol Sci 2005, 9(5):265-268.
11. Leclercq I.A., Horsmans Y. Nonalcoholic fatty liver disease: The potential role of nutritional management. Curr Opin Clin Nutr Metab Care 2008, 11(6):766-773.
12. Krasnoff J.B., Painter P.L., Wallace J.P., Bass N.M., Merriman R.B. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008, 47(4):1158-1166.
13. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., et al. Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study. Hepatology 2008, 48(6):1791-1798.
14. Caldwell S., Lazo M. Is exercise an effective treatment for NASH? Knowns and unknowns. Ann Hepatol 2009, 8(suppl 1):S60-S66.
15. Patel A.A., Torres D.M., Harrison S.A. Effect of weight loss on nonalcoholic fatty liver disease. JClin Gastroenterol 2009, 43(10):970-974.
16. Yasutake K., Nakamuta M., Shima Y., et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol. Scand J Gastroenterol 2009, 44(4):471-477.
17. Solga S., Alkhuraishe A.R., Clark J.M., et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 2004, 49(10):1578-1583.
18. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. JHepatol Nov 2007, 47(5):711-717.
19. Enjoji M., Nakamuta M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?. World J Gastroenterol 2010, 16(7):800-803.
20. Musso G., Gambino R., De Michieli F., et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37(4):909-916.
21. Cortez-Pinto H., Jesus L., Barros H., Lopes C., Moura M.C., Camilo M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients?. Clin Nutr 2006, 25(5):816-823.
22. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. JClin Gastroenterol 2006, 40(suppl 1):S5-S10.
23. Toshimitsu K., Matsuura B., Ohkubo I., et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007, 23(1):46-52.
24. Lim J.S., Mietus-Snyder M., Valente A., Schwarz J.M., Lustig R.H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010, 7(5):251-264.
25. Dietary Reference Intakes Tables. 2010. Accessed July 18,2011. http://www.hc-sc.gc.ca/fn-an/nutrition/reference/table/index_e.html.
26. Canadian Society for Exercise Physiology. Canadian Physical Activity Guidelines for Adults - 18-64 years. 2011. Accessed July 18,2011. http://www.csep.ca/CMFiles/Guidelines/CSEP-InfoSheets-adults-ENG.pdf.
27. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: A proposal for grading andstaging the histological lesions. Am J Gastroenterol 1999, 94(9):2467-2474.
28. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321.
29. Millen B., Morgan J.L. The 2D Food Portion Visual 1996, Nutrition Consulting Enterprises, Framingham, MA.
30. Mohammed S.S., Aghdassi E., Salit I.E., et al. HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients. JAcquir Immune Defic Syndr 2007, 45(4):432-438.
31. Madill J., Arendt B., Aghdassi E., et al. Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients. Transplant Proc 2010, 42(5):1744-1749.
32. Madill J., Aghdassi E., Arendt B.M., et al. Oxidative stress and nutritional intakes in lung patients with bronchiolitis obliterans syndrome. Transplant Proc 2009, 41(9):3838-3844.
33. White J.S. Challenging the fructose hypothesis: New perspectives onfructose consumption and metabolism. Adv Nutr 2013, 4(2):246-256.
34. Pan D.A., Lillioja S., Kriketos A.D., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46(6):983-988.
35. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride 1997, Institute of Medicine, National Academies Press, Washington, DC.
36. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline 1998, Institute of Medicine, National Academies Press, Washington, DC.
37. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2000, Institute of Medicine, National Academies Press, Washington, DC.
38. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids 2000, Institute of Medicine, National Academies Press, Washington, DC.
39. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate 2004, Institute of Medicine, National Academies Press, Washington, DC.
40. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2005, Institute of Medicine, National Academies Press, Washington, DC.
41. Committee to Review Dietary Reference Intakesfor Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D 2011, Institute of Medicine, National Academies Press, Washington, DC.
42. Krauss R.M., Eckel R.H., Howard B., et al. Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. JNutr 2001, 131(1):132-146.
43. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
44. Gunter E.W.T., Turner W.E., Neese J.W., Bayse D.D. Laboratory Procedures Used by the Clinical Chemistry Division, Centers for Disease Control, for the Second Health and Nutrition Examination Survey (HANES II) 1976-1980 1985, 17-20. Centers for Disease Control and Prevention, Atlanta, GA.
45. Statistics Canada. Overweight and obese adults (self-reported), 2010. Health Fact Sheets-Canadian Community Health Survey. 2011. Accessed April 20,2012. http://www.statcan.gc.ca/pub/82-625-x/2012001/article/11664-eng.htm.
46. Bedard D., Shatenstein B., Nadon S. Underreporting of energy intake from a self-administered food-frequency questionnaire completed by adults in Montreal. Public Health Nutr 2004, 7(5):675-681.
47. Pietilainen K.H., Korkeila M., Bogl L.H., et al. Inaccuracies in food and physical activity diaries of obese subjects: Complementary evidence from doubly labeled water and co-twin assessments. Int J Obes (Lond) 2010, 34(3):437-445.
48. Kim C.H., Kallman J.B., Bai C., et al. Nutritional assessments of patients with non-alcoholic fatty liver disease. Obes. Surg 2010, 20(2):154-160.
49. Sathiaraj E., Chutke M., Reddy M.Y., et al. Acase-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. Eur J Clin Nutr 2011, 65(4):533-537.
50. Hill R.J., Davies P.S. The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001, 85(4):415-430.
51. Mendez M.A., Wynter S., Wilks R., Forrester T. Under- and overreporting of energy is related to obesity, lifestyle factors and foodgroup intakes in Jamaican adults. Public Health Nutr 2004, 7(1):9-19.
52. Wang D., Wei Y., Pagliassotti M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006, 147(2):943-951.
53. Allard J.P., Aghdassi E., Mohammed S., et al. Nutritional assessment andhepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study. JHepatol 2008, 48(2):300-307.
54. Videla L.A., Rodrigo R., Orellana M., et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2004, 106(3):261-268.
55. Bhala N., Angulo P., van der Poorten D., et al. The natural history ofnonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology 2011, 54(4):1208-1216.
56. Kang H., Greenson J.K., Omo J.T., et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 2006, 101(10):2247-2253.
57. Ricci G., Canducci E., Pasini V., et al. Nutrient intake in Italian obese patients: Relationships with insulin resistance and markers of non-alcoholic fatty liver disease. Nutrition 2011, 27(6):672-676.
58. Tappy L., Le K.A., Tran C., Paquot N. Fructose and metabolic diseases:New findings, new questions. Nutrition 2010, 26(11-12):1044-1049.
59. Havel P.J. Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63(5):133-157.
60. Abdelmalek M.F., Suzuki A., Guy C., et al. Increased fructose consumption is associated with fibrosis severity in patients withnonalcoholic fatty liver disease. Hepatology 2010, 51(6):1961-1971.
61. Kawasaki T., Igarashi K., Koeda T., et al. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. JNutr 2009, 139(11):2067-2071.
62. Assy N., Nasser G., Kamayse I., et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008, 22(10):811-816.
63. Abid A., Taha O., Nseir W., Farah R., Grosovski M., Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. JHepatol 2009, 51(5):918-924.
64. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142(7):1592-1609.
65. LaBrecque D., Abbas Z., Anania F., et al. World Gastroenterology Organisation Global Guidelines: Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis June 2012, World Gastroenterology Organisation, Millwaukee, WI.
66. Dowman J.K., Tomlinson J.W., Newsome P.N. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010, 103(2):71-83.
67. Sies H., Stahl W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995, 62(6 suppl):1315S-1321S.
68. Kugelmas M., Hill D.B., Vivian B., Marsano L., McClain C.J. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003, 38(2):413-419.
69. Targher G., Bertolini L., Scala L., et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007, 17(7):517-524.
70. Kruger H.S., Rautenbach P.H., Venter C.S., Wright H.H., Schwarz P.E. An inverse association between calcium and adiposity in women with high fat and calcium intakes. Ethn Dis 2007, 17(1):6-13.
71. Siddiqui S.M., Chang E., Li J., et al. Dietary intervention with vitamin D, calcium, and whey protein reduced fat mass and increased lean mass in rats. Nutr Res 2008, 28(11):783-790.
72. Papakonstantinou E., Flatt W.P., Huth P.J., Harris R.B. High dietary calcium reduces body fat content, digestibility of fat, and serum vitamin D in rats. Obes Res 2003, 11(3):387-394.
73. Mazur A., Maier J.A., Rock E., Gueux E., Nowacki W., Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch Biochem Biophys 2007, 458(1):48-56.
74. Agarwal A.K., Jain V., Singla S., et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. JAssoc Physicians India 2011, 59:351-354.
75. Lu H., Zeng L., Liang B., Shu X., Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res 2009, 40(7):571-575.
76. Sumida Y., Yoshikawa T., Okanoue T. Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol Res 2009, 39(3):213-222.
77. Yamamoto M., Iwasa M., Iwata K., et al. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. JGastroenterol Hepatol 2007, 22(4):498-503.
78. Fujita N., Miyachi H., Tanaka H., et al. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. Cancer Epidemiol Biomarkers Prev 2009, 18(2):424-432.
79. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005, 28(12):2823-2831.
80. Vital signs: Food categories contributing the most to sodium consumption-United States, 2007-2008. MMWR Morb Mortal Wkly Rep 2012, 61(5):92-98. Centers for Disease Control and Prevention (CDC).
81. Mattes R.D., Donnelly D. Relative contributions of dietary sodium sources. JAm Coll Nutr 1991, 10(4):383-393.
82. Fodor J.G., Whitmore B., Leenen F., Larochelle P. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ May 4 1999, 160(9 suppl):S29-S34.
83. Thoma C., Day C.P., Trenell M.I. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review. JHepatol 2012, 56(1):255-266.
84. Statistics Canada. Physical activity during leisure time, 2010. HealthFact Sheets-Canadian Community Health Survey 2011. Accessed August 12,2011. http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11467-eng.htm.
85. Gill H.K., Wu G.Y. Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Arelow carbohydrate diets the answer?. World J Gastroenterol 2006, 12(3):345-353.
86. Kistler K.D., Brunt E.M., Clark J.M., Diehl A.M., Sallis J.F., Schwimmer J.B. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011, 106(3):460-468. quiz 469.
87. Daly A.K., Ballestri S., Carulli L., Loria P., Day C.P. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2011, 5(2):253-263.
88. Abu-Shanab A., Quigley E.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010, 7(12):691-701.
89. Johnson R.K. Dietary intake-How do we measure what people are really eating?. Obes Res 2002, 10(suppl 1):63S-68S.